Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 46Neoplasms 32Lung Neoplasms 25Colorectal Neoplasms 22Uterine Cervical Neoplasms 14Prostatic Neoplasms 13Motor Activity 11Colonic Neoplasms 10Anxiety Disorders 9Rectal Neoplasms 8Pancreatic Neoplasms 8Obesity 8Carcinoma, Non-Small-Cell Lung 8Hematologic Neoplasms 7Endometrial Neoplasms 7Depression 7Ovarian Neoplasms 6Lymphoma 6Breast Carcinoma In Situ 6Vulvar Neoplasms 5Urinary Bladder Neoplasms 5Neoplasm Metastasis 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Pain 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4

Interventions

Radiation Dose Hypofractionation 1Quality Indicators, Health Care 1Patient Transfer 1Methods 1Mass Screening 1Immunization, Secondary 1Early Intervention, Educational 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Financial Stress × Methods × Clear all
NCT05939440 2025-06-05

P-COC

University of Alabama at Birmingham

Phase NA Completed
60 enrolled
BreastGastrointestinalGynecologic

Financial Stress, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡